Qingxin Mu received his Ph.D. from Shandong University, China in 2010. From 2007 to 2012, he worked at St. Jude Children’s Research Hospital in Memphis, USA as an International Research Scholar and Postdoctoral Research Associate. From 2012 to 2013, he worked at Department of Pharmaceutical Chemistry in University of Kansas as a Postdoctoral Researcher. He is currently a NIH T32 Postdoctoral Research Fellow in Fred Hutchinson Cancer Research Center under Dr. Oliver Press and Department of Materials Science & Engineering in University of Washington under Prof. Miqin Zhang. His current research involves development of novel multifunctional magnetic drug nano-carriers for targeted chemotherapy of brain cancer and lymphoma.